Net income (loss) per share (Details) - shares |
3 Months Ended | |
|---|---|---|
Oct. 31, 2021 |
Oct. 31, 2020 |
|
| Net income (loss) per share (Details) [Line Items] | ||
| Potential common shares | 541,000 | |
| Weighted average stock options of diluted weighted average shares outstanding | 10,000 | |
| Out of the money options [Member] | ||
| Net income (loss) per share (Details) [Line Items] | ||
| Antidilutive securities excluded from computation of earnings per share, amount | 793,000 | 2,146,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|